1 INTRODUCTION New-onset diabetes after transplantation (NODAT) negatively impacts the long-term survival of both the patient and the graft.1 The incidence of new-onset diabetes within 1 year after transplantation has been reported to range from 2% to 50%, depending on the diagnostic criteria and type of immunosuppressants used.2 Although the recipient's age, race, family history of diabetes, and hepatitis C virus (HCV) infection have been reported to be associated with NODAT,3 so far, no...